NCT05169450View on ClinicalTrials.gov

Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

998

Participants

Timeline

Start Date

July 1, 2013

Primary Completion Date

April 1, 2014

Study Completion Date

April 1, 2014

Conditions
StrokeIschemic StrokeNervous System DiseasesCerebral InfarctionBrain IschemiaBrain Infarction
Interventions
DRUG

Diterpene ginkgolides meglumine injection

Patients will receive intravenously administered diterpene ginkgolides meglumine injection, combined with guidelines-based standard care.

DRUG

Ginaton

Patients will receive intravenously administered Ginaton, combined with guidelines-based standard care.

Trial Locations (1)

100700

Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER

NCT05169450 - Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke | Biotech Hunter | Biotech Hunter